• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Cytokinetics, Incorporated (CYTK)

    -NasdaqCM
    7.71 Down 0.25(3.14%) Feb 27, 4:00PM EST
    |After Hours : 7.72 Up 0.01 (0.07%) Feb 27, 4:32PM EST
    Add to Portfolio
    Prev Close:7.96
    Open:8.05
    Bid:N/A
    Ask:10.00 x 200
    1y Target Est:13.80
    Beta:1.43
    Earnings Date:May 4 - May 8 (Est.)
    Day's Range:7.68 - 8.07
    52wk Range:3.05 - 13.26
    Volume:379,806
    Avg Vol (3m):547,159
    Market Cap:283.33M
    P/E (ttm):N/A
    EPS (ttm):-0.41
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CYTKDown 3.14%283.33M
    BIIBDown 0.12%96.10B
    LGNDDown 1.34%1.08B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):6.23
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.99
    Quarterly EPS Est (Mar-15) :-0.12
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-0.52

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cytokinetics, Incorporated, a clinical stage biopharmaceutical company, focuses on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditi... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback